- Source : Press Release
- Date : 2018-05-16
- Companies : Frontage Laboratories, Inc.
Dr. Song Li Wins Healthcare CEO Enterprise Award
Dr. Song Li, Founder and CEO of Frontage Laboratories, Inc., has been awarded the Healthcare CEO of the Year Enterprise Award for 2018.
Sponsored by PACT (Philadelphia Alliance for Capital and Technologies), this award recognizes extraordinary business leaders in healthcare and technology in the greater Philadelphia region.
The Healthcare CEO Award recognizes Dr. Li’s management accomplishments and philosophy, leadership and impact in industry, financial accomplishments, and his ongoing strategy for continued company success.
“It’s a great honor for me to win this Healthcare CEO Award. In 2001, I founded Frontage Laboratories in New Jersey with a $100,000 investment. In the last 17 years, Frontage has grown from a one-man testing lab to a 700-employee CRO company with fully integrated services for pharmaceutical product development. During this 17-year journey, many people have given me unconditional support. I would like to take this opportunity to express my appreciation to many people who have given me the support and made great contributions to Frontage’s success,” said Dr. Song Li.
For more information visit: www.frontagelab.com/about/news-item/enterprise-award/
Frontage, a full service early-stage CRO with 14 locations in USA and China, has been assisting global biopharmaceutical organizations in their drug development efforts since 2001. Spanning from discovery through late-stage development, its full service offerings include DMPK, bioanalysis using over 60 LC-MS/MS instruments, analytical testing, product development, and full biometrics support. Frontage also provides turnkey product development services to generic, innovator and consumer health pharmaceutical companies to support IND, NDA, ANDA, and 505(b)(2) submissions. Frontage has successfully enabled biopharmaceutical and generic companies of all sizes to advance hundreds of molecules through clinical development to commercial launch in global markets.